Strategic position PeproTech is now part of Thermo Fisher Scientific, placing it within a vast global corporate ecosystem with access to Thermo Fisher's extensive distribution, customer base, and cross-selling opportunities in life science research and cell therapy markets.

Cytokine focus Specialization in recombinant cytokines for life-science research suggests frequent demand for high-quality biologics reagents, offering upsell potential for complementary Thermo Fisher products such as analytical instruments, cell culture media, and assay kits.

Mid-market footprint Employee count and revenue indicate a mid-market profile with room to scale; targeted outreach to academic labs, biotech startups, and contract research organizations could yield high ROI through Thermo Fisher’s broader portfolio.

Tech ecosystem Existing tech stack including multiple enterprise and R&D tools signals compatibility with Thermo Fisher’s digital platforms and service ecosystems, enabling integrated procurement solutions and data-driven order fulfilment for customers.

Expansion leverage Recent Thermo Fisher product launches and collaborations across spectroscopy, HLA diagnostics, and mRNA therapies indicate cross-sell opportunities for PeproTech customers to adopt related Thermo Fisher innovations and services as research needs evolve.